{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,31]],"date-time":"2026-10-31T03:07:07Z","timestamp":1793416027948,"version":"4.5.0"},"reference-count":20,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,12,25]],"date-time":"2022-12-25T00:00:00Z","timestamp":1671926400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,12,25]],"date-time":"2022-12-25T00:00:00Z","timestamp":1671926400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100000268","name":"Biotechnology and Biological Sciences Research Council","doi-asserted-by":"publisher","award":["BB\/R020116\/1"],"award-info":[{"award-number":["BB\/R020116\/1"]}],"id":[{"id":"10.13039\/501100000268","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002992","name":"Department for International Development","doi-asserted-by":"publisher","award":["216619\/Z\/19\/Z"],"award-info":[{"award-number":["216619\/Z\/19\/Z"]}],"id":[{"id":"10.13039\/501100002992","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000060","name":"National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["U01HG007480"],"award-info":[{"award-number":["U01HG007480"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004421","name":"World Bank Group","doi-asserted-by":"publisher","award":["ACE-IMPACT"],"award-info":[{"award-number":["ACE-IMPACT"]}],"id":[{"id":"10.13039\/100004421","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000877","name":"Rockefeller Foundation","doi-asserted-by":"publisher","award":["Grant #2021 HTH"],"award-info":[{"award-number":["Grant #2021 HTH"]}],"id":[{"id":"10.13039\/100000877","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Africa Centre for Disease Control","award":["INV018978"],"award-info":[{"award-number":["INV018978"]}]},{"name":"Science for Africa Foundation"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Elucidating the adaptive immune characteristics of natural protection to Lassa fever (LF) is vital in designing and selecting optimal vaccine candidates. With rejuvenated interest in LF and a call for accelerated research on the Lassa virus (LASV) vaccine, there is a need to define the correlates of natural protective immune responses to LF. Here, we describe cellular and antibody immune responses present in survivors of LF (N\u2009=\u2009370) and their exposed contacts (N\u2009=\u2009170) in a LASV endemic region in Nigeria. Interestingly, our data showed comparable T cell and binding antibody responses from both survivors and their contacts, while neutralizing antibody responses were primarily seen in the LF survivors and not their contacts. Neutralizing antibody responses were found to be cross-reactive against all five lineages of LASV with a strong bias to Lineage II, the prevalent strain in southern Nigeria. We demonstrated that both T cell and antibody responses were not detectable in peripheral blood after a decade in LF survivors. Notably LF survivors maintained high levels of detectable\u00a0binding antibody response for six months while their contacts did not. Lastly, as potential vaccine targets, we identified the regions of the LASV Glycoprotein (GP) and Nucleoprotein (NP) that induced the broadest peptide-specific T cell responses. Taken together this data informs immunological readouts and potential benchmarks for clinical trials evaluating LASV vaccine candidates.<\/jats:p>","DOI":"10.1038\/s41598-022-26045-w","type":"journal-article","created":{"date-parts":[[2022,12,25]],"date-time":"2022-12-25T11:02:42Z","timestamp":1671966162000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":24,"title":["Humoral and cellular immune responses to Lassa fever virus in Lassa fever survivors and their exposed contacts in Southern Nigeria"],"prefix":"10.1038","volume":"12","author":[{"given":"Chinedu","family":"Ugwu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Testimony","family":"Olumade","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ebenezer","family":"Nwakpakpa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Venatius","family":"Onyia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elizabeth","family":"Odeh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rosemary Ogonna","family":"Duruiheoma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chiedozie K.","family":"Ojide","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew Afam","family":"Eke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ifeanyi Emmanuel","family":"Nwafor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nneka","family":"Chika-Igwenyi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Augustine M.","family":"Abu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benedict","family":"Azuogu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nnennaya","family":"Ajayi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emeka","family":"Ogah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Oluwafemi","family":"Ayodeji","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chukwuyem","family":"Abejegah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nelson","family":"Adedosu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicholas","family":"Oyejide","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sylvester","family":"Abah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abiola","family":"Omidele","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Winifred","family":"Ingbian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emmanuel","family":"Osoba","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philomena","family":"Eromon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul","family":"Oluniyi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olusola","family":"Ogunsanya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anise","family":"Happi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patricia","family":"Otuh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angalee","family":"Nadesalingam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"George","family":"Carnell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nina","family":"Krause","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ernest","family":"Aguinam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rebecca","family":"Kinsley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel Matthew L.","family":"Storisteanu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul","family":"Tonks","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Diana","family":"Nelson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carley","family":"McAlister","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew","family":"Boisen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert","family":"Garry","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edward","family":"Wright","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nigel","family":"Temperton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simon","family":"Frost","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonathan Luke","family":"Heeney","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christian","family":"Happi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,12,25]]},"reference":[{"key":"26045_CR1","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1128\/JVI.00929-19","volume":"93","author":"DU Ehichioya","year":"2019","unstructured":"Ehichioya, D. U. et al. Phylogeography of Lassa virus in Nigeria. J. Virol. 93, 1\u201312 (2019).","journal-title":"J. Virol."},{"key":"26045_CR2","first-page":"69","volume":"134","author":"JB McCormick","year":"1987","unstructured":"McCormick, J. B. Epidemiology and control of Lassa fever. Curr. Top. Microbiol. Immunol. 134, 69\u201378 (1987).","journal-title":"Curr. Top. Microbiol. Immunol."},{"key":"26045_CR3","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12879-021-05837-x","volume":"21","author":"CA Yaro","year":"2021","unstructured":"Yaro, C. A. et al. Infection pattern, case fatality rate and spread of Lassa virus in Nigeria. BMC Infect. Dis. 21, 1\u20139 (2021).","journal-title":"BMC Infect. Dis."},{"key":"26045_CR4","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1804498","author":"KJ Siddle","year":"2018","unstructured":"Siddle, K. J. et al. Genomic analysis of Lassa virus during an increase in cases in Nigeria in 2018. N. Engl. J. Med. https:\/\/doi.org\/10.1056\/NEJMoa1804498 (2018).","journal-title":"N. Engl. J. Med."},{"key":"26045_CR5","doi-asserted-by":"publisher","first-page":"4135","DOI":"10.1016\/j.vaccine.2020.01.017","volume":"38","author":"K Salami","year":"2020","unstructured":"Salami, K. et al. Meeting report: WHO consultation on accelerating Lassa fever vaccine development in endemic countries, Dakar, 10\u201311 September 2019. Vaccine 38, 4135\u20134141 (2020).","journal-title":"Vaccine"},{"key":"26045_CR6","unstructured":"Coalition for Epidemic Preparedness Innovations. Largest Ever Lassa Fever Study Expands to More Countries in West Africa 1\u20134 (2021)."},{"key":"26045_CR7","doi-asserted-by":"publisher","DOI":"10.1038\/s41541-021-00291-x","author":"RJ Fischer","year":"2021","unstructured":"Fischer, R. J. et al. ChAdOx1-vectored Lassa fever vaccine elicits a robust cellular and humoral immune response and protects guinea pigs against lethal Lassa virus challenge. npj Vaccines https:\/\/doi.org\/10.1038\/s41541-021-00291-x (2021).","journal-title":"npj Vaccines"},{"key":"26045_CR8","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41598-020-72539-w","volume":"10","author":"ML Heinrich","year":"2020","unstructured":"Heinrich, M. L. et al. Antibodies from Sierra Leonean and Nigerian Lassa fever survivors cross-react with recombinant proteins representing Lassa viruses of divergent lineages. Sci. Rep. 10, 1\u201319 (2020).","journal-title":"Sci. Rep."},{"key":"26045_CR9","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1371\/journal.ppat.1008352","volume":"16","author":"BM Sullivan","year":"2020","unstructured":"Sullivan, B. M. et al. High crossreactivity of human T cell responses between Lassa virus lineages. PLoS Pathog. 16, 1\u201319 (2020).","journal-title":"PLoS Pathog."},{"key":"26045_CR10","doi-asserted-by":"publisher","first-page":"1","DOI":"10.12688\/f1000research.16989.1","volume":"8","author":"IS Lukashevich","year":"2019","unstructured":"Lukashevich, I. S., Paessler, S., Carlos, J. & Torre, D. Lassa virus diversity and feasibility for universal prophylactic vaccine [version 1; referees: 3 approved] Referee Status. F1000Research 8, 1\u201312 (2019).","journal-title":"F1000Research"},{"key":"26045_CR11","doi-asserted-by":"publisher","first-page":"738","DOI":"10.1016\/j.cell.2015.07.020","volume":"162","author":"KG Andersen","year":"2015","unstructured":"Andersen, K. G. et al. Clinical sequencing uncovers origins and evolution of Lassa virus. Cell 162, 738\u2013750 (2015).","journal-title":"Cell"},{"key":"26045_CR12","doi-asserted-by":"publisher","first-page":"e152379","DOI":"10.1172\/JCI152379","volume":"131","author":"AT Tan","year":"2021","unstructured":"Tan, A. T. et al. Rapid measurement of SARS-CoV-2 spike T cells in whole blood from vaccinated and naturally infected individuals. J. Clin. Investig. 131, e152379 (2021).","journal-title":"J. Clin. Investig."},{"key":"26045_CR13","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3390\/v13112325","volume":"13","author":"R Borrega","year":"2021","unstructured":"Borrega, R. et al. Cross-reactive antibodies to sars-cov-2 and mers-cov in pre-covid-19 blood samples from sierra leoneans. Viruses 13, 1\u201319 (2021).","journal-title":"Viruses"},{"key":"26045_CR14","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41598-018-24246-w","volume":"8","author":"ML Boisen","year":"2018","unstructured":"Boisen, M. L. et al. Field validation of recombinant antigen immunoassays for diagnosis of Lassa fever. Sci. Rep. 8, 1\u201314 (2018).","journal-title":"Sci. Rep."},{"key":"26045_CR15","unstructured":"Coalition for Epidemic Preparedness Innovations. Lassa Epidemiological Studies for Preparation of Clinical Trials in Affected Countries 1\u20136 (2018)."},{"key":"26045_CR16","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41598-022-15791-6","volume":"12","author":"A Sancilio","year":"2022","unstructured":"Sancilio, A. et al. COVID-19 symptom severity predicts neutralizing antibody activity in a community-based serological study. Sci. Rep. 12, 1\u20137 (2022).","journal-title":"Sci. Rep."},{"key":"26045_CR17","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1371\/journal.pntd.0006187","volume":"12","author":"EJ Mateer","year":"2018","unstructured":"Mateer, E. J., Huang, C., Shehu, N. Y. & Paessler, S. Lassa fever\u2013induced sensorineural hearing loss: A neglected public health and social burden. PLoS Negl. Trop. Dis. 12, 1\u201311 (2018).","journal-title":"PLoS Negl. Trop. Dis."},{"key":"26045_CR18","doi-asserted-by":"publisher","first-page":"2186","DOI":"10.1128\/JVI.74.5.2186-2192.2000","volume":"74","author":"J ter Meulen","year":"2000","unstructured":"ter Meulen, J. et al. Characterization of human CD4+ T-Cell clones recognizing conserved and variable epitopes of the Lassa virus nucleoprotein. J. Virol. 74, 2186\u20132192 (2000).","journal-title":"J. Virol."},{"key":"26045_CR19","doi-asserted-by":"publisher","first-page":"772","DOI":"10.1093\/molbev\/mst010","volume":"30","author":"K Katoh","year":"2013","unstructured":"Katoh, K. & Standley, D. M. MAFFT multiple sequence alignment software version 7: Improvements in performance and usability. Mol. Biol. Evol. 30, 772\u2013780 (2013).","journal-title":"Mol. Biol. Evol."},{"key":"26045_CR20","doi-asserted-by":"publisher","DOI":"10.3390\/mps1010008","author":"F Ferrara","year":"2018","unstructured":"Ferrara, F. Pseudotype neutralization assays: From laboratory bench to data analysis. Methods Protoc. https:\/\/doi.org\/10.3390\/mps1010008 (2018).","journal-title":"Methods Protoc."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-022-26045-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-022-26045-w","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-022-26045-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,28]],"date-time":"2022-12-28T15:13:55Z","timestamp":1672240435000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-022-26045-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,12,25]]},"references-count":20,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2022,12]]}},"alternative-id":["26045"],"URL":"https:\/\/doi.org\/10.1038\/s41598-022-26045-w","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,12,25]]},"assertion":[{"value":"17 October 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 December 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 December 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"22330"}}